American International Group Inc. Sells 5,298 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

American International Group Inc. lowered its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 4.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 124,541 shares of the company’s stock after selling 5,298 shares during the quarter. American International Group Inc. owned about 0.14% of Acadia Healthcare worth $9,684,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Iron Triangle Partners LP raised its stake in Acadia Healthcare by 3.5% during the 4th quarter. Iron Triangle Partners LP now owns 791,993 shares of the company’s stock valued at $61,585,000 after purchasing an additional 26,789 shares during the period. 8 Knots Management LLC bought a new stake in Acadia Healthcare during the 4th quarter valued at approximately $2,582,000. Avidity Partners Management LP raised its stake in Acadia Healthcare by 61.8% during the 4th quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock valued at $89,944,000 after purchasing an additional 441,692 shares during the period. Sea Cliff Partners Management LP bought a new stake in Acadia Healthcare during the 4th quarter valued at approximately $26,338,000. Finally, Rhenman & Partners Asset Management AB bought a new stake in Acadia Healthcare during the 4th quarter valued at approximately $1,448,000.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock opened at $68.29 on Wednesday. The stock has a market cap of $6.34 billion, a price-to-earnings ratio of -483.39, a price-to-earnings-growth ratio of 1.96 and a beta of 1.32. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.27 and a current ratio of 1.27. The stock has a 50 day moving average price of $69.31 and a 200-day moving average price of $76.26. Acadia Healthcare Company, Inc. has a one year low of $62.04 and a one year high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Thursday, May 2nd. The company reported $0.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The company had revenue of $768.10 million during the quarter, compared to analysts’ expectations of $779.20 million. During the same quarter in the previous year, the business earned $0.75 EPS. Acadia Healthcare’s revenue was up 9.1% compared to the same quarter last year. Equities analysts expect that Acadia Healthcare Company, Inc. will post 3.52 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, March 5th. Mizuho reduced their price objective on Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating on the stock in a research note on Friday, May 3rd. UBS Group lifted their price objective on Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research note on Wednesday, February 28th. TheStreet raised Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. Finally, Barclays reduced their price objective on Acadia Healthcare from $91.00 to $89.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 15th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $87.56.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.